JBIO

NASDAQ · Biotechnology

Jade Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.06

-0.18 (-1.26%)

As of Nov 7, 1:59 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +160.8% upside

Low Target $19.65

Average Target $36.67

High Target $47.67

Current Price $14.06

Current
$14.06

Target
$36.67

$19.65 $36.67 avg $47.67

Scenario Analysis

Bear Case

$19.65

39.8%

Low target

Base Case

$36.67

+160.8%

Avg target

Bull Case

$47.67

+239.0%

High target

Risk/Reward

6.0x

Highly favorable

Price in Context

52-Week High

$28.00

-49.8% from high

52-Week Low

$8.36

+68.2% from low

Target vs 52W High

$36.67

+31.0% vs high

Next Earnings Report

Nov 11, 2026 · After Market Close

until earnings

EPS Est: $-0.73

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%